January 12, 2022 -- Rheonix announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to its automated workstation software and molecular test for sexually transmitted infections (STIs).
The Encompass MDx workstation enables scalable, multiplexed sample-to-answer detection, simplifying laboratory workflows.
The Rheonix STI triplex assay and male urine collection kit is approved for simultaneous detection and differentiation of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis.
Copyright © 2022 LabPulse.com
Last Updated ls 1/12/2022 3:18:18 PM
Subscribe Today
Do you want to be a Microbiology Insider?
When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.
Yes, Keep Me Current